Mu‐Kuan Chen

7.8k total citations
169 papers, 4.0k citations indexed

About

Mu‐Kuan Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mu‐Kuan Chen has authored 169 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 40 papers in Oncology and 40 papers in Cancer Research. Recurrent topics in Mu‐Kuan Chen's work include Head and Neck Cancer Studies (35 papers), Head and Neck Surgical Oncology (20 papers) and Protease and Inhibitor Mechanisms (17 papers). Mu‐Kuan Chen is often cited by papers focused on Head and Neck Cancer Studies (35 papers), Head and Neck Surgical Oncology (20 papers) and Protease and Inhibitor Mechanisms (17 papers). Mu‐Kuan Chen collaborates with scholars based in Taiwan, United States and United Kingdom. Mu‐Kuan Chen's co-authors include Shun‐Fa Yang, Ming‐Ju Hsieh, Chiao‐Wen Lin, Yu‐Sheng Lo, Yi‐Ching Chuang, Hui‐Ling Chiou, Chia‐Chieh Lin, Su‐Yu Chien, Jen‐Tsun Lin and Yi‐Ting Hsi and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer.

In The Last Decade

Mu‐Kuan Chen

165 papers receiving 3.9k citations

Peers

Countries citing papers authored by Mu‐Kuan Chen

Since Specialization

Citations

This map shows the geographic impact of Mu‐Kuan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu‐Kuan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu‐Kuan Chen more than expected).

Fields of papers citing papers by Mu‐Kuan Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mu‐Kuan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu‐Kuan Chen. The network helps show where Mu‐Kuan Chen may publish in the future.

Co-authorship network of co-authors of Mu‐Kuan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Mu‐Kuan Chen. A scholar is included among the top collaborators of Mu‐Kuan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mu‐Kuan Chen. Mu‐Kuan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pyrocurzerenone suppresses human oral cancer cell metastasis by inhibiting the expression of ERK1/2 and cathepsin S proteins 2024 ·Journal of Cellular and Molecular Medicine ·Ming‐Ju Hsieh, Chia‐Chieh Lin, Hsin‐Yu Ho, Yi‐Ching Chuang, Yu‐Sheng Lo, Mu‐Kuan Chen	2
2	Arenobufagin induces cell apoptosis by modulating the cell cycle regulator claspin and the JNK pathway in nasopharyngeal carcinoma cells 2024 ·Expert Opinion on Therapeutic Targets ·Hsin‐Yu Ho, Mu‐Kuan Chen, (unknown), Yu‐Sheng Lo, Yi‐Ching Chuang, Ming‐Ju Hsieh	4
3	Limocitrin increases cytotoxicity of KHYG‐1 cells against K562 cells by modulating MAPK pathway 2023 ·Environmental Toxicology ·Ming‐Ju Hsieh, Jen‐Tsun Lin, Yi‐Ching Chuang, Chia‐Chieh Lin, Yu‐Sheng Lo, Hsin‐Yu Ho, Mu‐Kuan Chen	1
4	Hispolon induces apoptosis in oral squamous cell carcinoma cells through JNK/HO‐1 pathway activation 2023 ·Journal of Cellular and Molecular Medicine ·Wei‐En Yang, Yi‐Tzu Chen, Chun‐Wen Su, Mu‐Kuan Chen, Chia‐Ming Yeh, (unknown), (unknown), Shun‐Fa Yang, Chiao‐Wen Lin	11
5	FAM13A polymorphisms are associated with a specific susceptibility to clinical progression of oral cancer in alcohol drinkers 2023 ·BMC Cancer ·Ming‐Ju Hsieh, Yu‐Sheng Lo, (unknown), Hsin‐Yu Ho, (unknown), Yi‐Ching Chuang, Shu‐Hui Lin, Mu‐Kuan Chen	6
6	Narciclasine suppresses oral cancer metastasis by modulating cathepsin B and extracellular signal–related kinase pathways 2022 ·Biomedicine & Pharmacotherapy ·(unknown), Hsin‐Yu Ho, (unknown), Yu‐Sheng Lo, Yi‐Ching Chuang, Ming‐Ju Hsieh, Mu‐Kuan Chen	8
7	Relationship between Preoperative Nutritional Status and Clinical Outcomes in Patients with Head and Neck Cancer 2022 ·Nutrients ·(unknown), Mu‐Kuan Chen, (unknown), Chew‐Teng Kor, Yen‐Tze Liu	6
8	An LRFM Model to Analyze Outpatient Loyalty From a Medical Center in Taiwan 2021 ·SAGE Open ·(unknown), Mu‐Kuan Chen, Hsin‐Hung Wu	2
9	An Empirical Study of Hospital’s Outpatient Loyalty From a Medical Center in Taiwan 2021 ·SAGE Open ·(unknown), Mu‐Kuan Chen, Hsin‐Hung Wu	2
10	Genetic Variants of lncRNA GAS5 Are Associated with the Clinicopathologic Development of Oral Cancer 2021 ·Journal of Personalized Medicine ·Ming‐Hong Hsieh, Hsueh‐Ju Lu, Chiao‐Wen Lin, Chia‐Yi Lee, (unknown), (unknown), Pei‐Hsuan Wu, Mu‐Kuan Chen, Shun‐Fa Yang	13
11	Inhibitory effects of Leucaena leucocephala on the metastasis and invasion of human oral cancer cells 2017 ·Environmental Toxicology ·Hsiao‐Hang Chung, Mu‐Kuan Chen, Yu‐Chao Chang, Shun‐Fa Yang, Chia‐Chieh Lin, Chiao‐Wen Lin, (unknown), (unknown)	20
12	Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities 2017 ·Theranostics ·Shih‐Chi Su, Chiao‐Wen Lin, Yu‐Fan Liu, Wen‐Lang Fan, Mu‐Kuan Chen, Chun-Ping Yu, Wei‐En Yang, Chun‐Wen Su, Chun‐Yi Chuang, Wen‐Hsiung Li, Wen‐Hung Chung, Shun‐Fa Yang	111
13	Dehydroandrographolide inhibits oral cancer cell migration and invasion through NF-κB-, AP-1-, and SP-1-modulated matrix metalloproteinase-2 inhibition 2017 ·Biochemical Pharmacology ·Ming‐Ju Hsieh, Jui‐Chieh Chen, Wei‐En Yang, Su‐Yu Chien, Mu‐Kuan Chen, Yu‐Sheng Lo, Yi‐Ting Hsi, Yi‐Ching Chuang, (unknown), Shun‐Fa Yang	52
14	Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression 2016 ·International Journal of Medical Sciences ·Chun‐Wen Su, (unknown), (unknown), Shun‐Fa Yang, Mu‐Kuan Chen, Chiao‐Wen Lin	26
15	Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3 2015 ·Medicine ·Chun‐Wen Su, Yi-Wen Huang, Mu‐Kuan Chen, Shih‐Chi Su, Shun‐Fa Yang, (unknown)	29
16	Effects of E‐cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathologic development of oral cancer 2011 ·Head & Neck ·Ming‐Hsien Chien, (unknown), (unknown), Chien‐Huang Lin, Ming‐Yung Chou, Meng‐Shih Weng, Shun‐Fa Yang, Mu‐Kuan Chen	17
17	Single Nucleotide Polymorphisms and Haplotypes of MMP-14 are Associated with the Risk and Pathological Development of Oral Cancer 2011 ·Annals of Surgical Oncology ·Chia‐Jui Weng, Mu‐Kuan Chen, Chiao‐Wen Lin, (unknown), Shun‐Fa Yang	16
18	The neoplastic impact of tobacco‐free betel‐quid on the histological type and the anatomical site of aerodigestive tract cancers 2011 ·International Journal of Cancer ·Chien‐Hung Lee, Ka‐Wo Lee, Fu‐Min Fang, Deng‐Chyang Wu, Shih‐Meng Tsai, Ping‐Ho Chen, Tien‐Yu Shieh, Chung‐Ho Chen, I‐Chen Wu, Hsiao‐Ling Huang, Bai‐Hsiun Chen, Cheng‐Hsien Chang, Mu‐Kuan Chen, Shah‐Hwa Chou, Yi‐Shan Tsai, Shang‐Lun Chiang, Ying‐Chin Ko	44
19	Clinical Features and Management of Distant Metastases from Nasopharyngeal Carcinoma 2008 ·(unknown), Mu-Tai Liu, (unknown), Mu‐Kuan Chen, Tung‐Hao Chang, (unknown), Chih-Chieh Hsu	2
20	Primary Tumour Volume Delineation in Nasopharyngeal Carcinoma and Correlation with 1997 AJCC Tumour Stage Classification 2001 ·The Journal of Otolaryngology ·(unknown), Mu‐Kuan Chen, (unknown), (unknown), Hwa‐Koon Wu, (unknown), (unknown), (unknown), (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact